Table 3.
Magnetic bead panel immunoassay of cytokines from supernatants of T cells cultures with myelin oligodendrocyte glycoprotein in long-term recall assay
| Control | HSCT | Natalizumab | ||||
|---|---|---|---|---|---|---|
| Detected | Mean value (pg/ml) | Detected | Mean value (pg/ml) | Detected | Mean value (pg/ml) | |
| IFN-γ | 7/7 | 17·09 (±29·46) | 6/6 | 5·28(± 2·73) | 7/7 | 9·41 (± 8·90) |
| IL-1β | 7/7 | 2·12 (± 0·41) | 6/6 | 1·90 (± 0·46) | 7/7 | 2·69 (± 0·94) |
| IL-6 | 3/7 | 6·80 (± 7·48) | 3/6 | 8·64 (± 3·71) | 4/7 | 9·51 (± 7·76) |
| IL-10 | 7/7 | 5·84 (± 3·17) | 6/6 | 3·08 (± 0·71) | 7/7 | 5·15 (1·62) |
| IL-17 | 3/7 | 3·66 (± 0·85) | 0/6 | n/a | 4/7 | 4·42 (1·75) |
| TGF-β1 | 3/7 | 33443 (± 15977) | 6/6 | 32849 (± 16296) | 7/7 | 20954 (± 7562) |
| TGF-β2 | 7/7 | 468 (± 42·1) | 6/6 | 469 (± 48·9) | 7/7 | 428 (± 53·2) |
| TGF-β3 | 7/7 | 32 (± 8·83) | 6/6 | 32 (± 4·52) | 7/7 | 27 (± 4·63) |
HSCT, haematopoietic stem cell transplant; IFN-γ, interferon-γ; IL-1β, interleukin-1β; n/a, not applicable; TGF-β1, transforming growth factor-β1.
Means (SD).
Differences are not statistically significant.